JPS61103898A - 生物学的に活性なペンタペプチド類及びヘプタペプチド類 - Google Patents

生物学的に活性なペンタペプチド類及びヘプタペプチド類

Info

Publication number
JPS61103898A
JPS61103898A JP60233569A JP23356985A JPS61103898A JP S61103898 A JPS61103898 A JP S61103898A JP 60233569 A JP60233569 A JP 60233569A JP 23356985 A JP23356985 A JP 23356985A JP S61103898 A JPS61103898 A JP S61103898A
Authority
JP
Japan
Prior art keywords
tyr
phe
ala
pharmaceutically acceptable
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60233569A
Other languages
English (en)
Japanese (ja)
Inventor
マリア・アントニエツタ・セルヴイーニ
ロベルト・デ・カステイグリオーネ
レンツオ・メナ
ジユーセツプ・ペルセオ
アレスサンドロ・ロツシ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of JPS61103898A publication Critical patent/JPS61103898A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP60233569A 1984-10-25 1985-10-21 生物学的に活性なペンタペプチド類及びヘプタペプチド類 Pending JPS61103898A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8427027 1984-10-25
GB08427027A GB2166139B (en) 1984-10-25 1984-10-25 Biologically active penta-and heptapeptides

Publications (1)

Publication Number Publication Date
JPS61103898A true JPS61103898A (ja) 1986-05-22

Family

ID=10568753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60233569A Pending JPS61103898A (ja) 1984-10-25 1985-10-21 生物学的に活性なペンタペプチド類及びヘプタペプチド類

Country Status (4)

Country Link
JP (1) JPS61103898A (fr)
BE (1) BE903493A (fr)
DE (1) DE3537405A1 (fr)
GB (1) GB2166139B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024421A1 (fr) * 1994-03-11 1995-09-14 Daiichi Pharmaceutical Co., Ltd. Derive peptidique
WO1997010262A1 (fr) * 1995-09-11 1997-03-20 Daiichi Pharmaceutical Co., Ltd. Derives peptidiques

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051685A (en) * 1994-03-11 2000-04-18 Daiichi Pharmaceuticals Co., Ltd. Peptide derivatives
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
DE3333752A1 (de) * 1983-09-19 1985-04-11 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024421A1 (fr) * 1994-03-11 1995-09-14 Daiichi Pharmaceutical Co., Ltd. Derive peptidique
WO1997010262A1 (fr) * 1995-09-11 1997-03-20 Daiichi Pharmaceutical Co., Ltd. Derives peptidiques

Also Published As

Publication number Publication date
BE903493A (fr) 1986-04-22
GB2166139B (en) 1988-06-22
GB8427027D0 (en) 1984-11-28
GB2166139A (en) 1986-04-30
DE3537405A1 (de) 1986-04-30

Similar Documents

Publication Publication Date Title
US4171299A (en) Polypeptide agents for blocking the human allergic response
US7071168B2 (en) Anti-cancer compounds and methods related thereto
US4707468A (en) Polypeptide
DE2602443A1 (de) Biologisch aktive polypeptide
AU696429B2 (en) Bradykinin antagonist peptides incorporating n-substituted glycines
JPH07121956B2 (ja) ブラジキニンアンタゴニスト作用を有するペプチド
JP2001505872A (ja) α―ヒドロキシ酸リンカーを含むペプチドプロドラッグ
JPH03504013A (ja) T細胞ヘルパー活性を有するペプチド
HU186749B (en) Process for preparing new, biologically active peptides
HRP970630A2 (en) Hepapeptide oxytocin analogues
IE913582A1 (en) Cyclopeptides
US4207311A (en) Peptides having analgesic and thermoregulative properties
JPS61191698A (ja) 新規な環状ヘキサペプチドlhrh拮抗剤
WO2006064530A2 (fr) Analogues de la dermorphine a activite analgesique
US4371463A (en) Enzyme-resistant opiate pentapeptides
JPS61103898A (ja) 生物学的に活性なペンタペプチド類及びヘプタペプチド類
EP0339193B1 (fr) Ligands peptides pour récepteurs de bombesine
EP0334685B1 (fr) Analogues de Bradykinine, leur synthèse et leur emploi en thérapeutique
CA1246059A (fr) Polypeptide-diesters; preparation et utilisation
US4001199A (en) Novel polypeptides useful for treating diabetes and hypercholesteremia
HU177133B (en) Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
EP0175323B1 (fr) Peptides à activité biologique, leurs procédés de préparation et compositions pharmaceutiques
DE60032822T2 (de) Analoge der substanz p zur behandlung von krebs
DE3333752A1 (de) Pharmakologisch aktive peptide
JPS6365680B2 (fr)